Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 188.59 |
| Open | 189.00 |
| Bid | 188.29 x 200 |
| Ask | 188.42 x 100 |
| Day's Range | 186.91 - 189.43 |
| 52 Week Range | 181.31 - 269.43 |
| Volume | |
| Avg. Volume | 1,096,564 |
| Market Cap | 27.44B |
| Beta (5Y Monthly) | -0.06 |
| PE Ratio (TTM) | 23.76 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Investor's Business Daily
Is Eli Lilly Stock A Buy After Snagging Approval For A New Eczema Drug?
The Food and Drug Administration signed off on a new eczema drug from Eli Lilly. Is Eli Lilly stock a buy right now?
- Zacks
Will Biogen (BIIB) Beat Estimates Again in Its Next Earnings Report?
Biogen (BIIB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- Zacks
Why Biogen Inc. (BIIB) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
© 2024 Yahoo. All rights reserved.